Participated in Wellumio's $7.28M first close pre-Series A for portable MRI stroke diagnostics.
Wellumio is redefining acute stroke care with Axana, a portable brain imaging solution that enhances rapid diagnosis during the critical Golden Hour after a stroke
Wellumio is redefining acute stroke care with Axana, a portable brain imaging solution that enhances rapid diagnosis during the critical Golden Hour after a stroke.